Literature DB >> 8823020

Comparison of polydioxanone and polyglactin 910 in intradermal repair.

B Guyuron1, C Vaughan.   

Abstract

A prospective clinical study was undertaken to compare the results of intradermal layer closure using two popular absorbable suture materials, polydioxanone and polyglactin 910. On an alternating basis, 6-0 polydioxanone and 6-0 polyglactin 910 were used to repair 80 surgical sites of the temple and occipital regions in 20 patients undergoing facial rhytidectomy. In all instances, the superficial skin layer was repaired with 6-0 plain catgut. These sites were evaluated by a double-blind method for erythema, induration, infection, scar spread, and hypertrophic scarring at approximately 5 months and at least 1 year postoperatively. Scar spread was indicated at widths greater than 1 mm. Any raised scar was labeled hypertrophic. Scar spread, as defined above, was observed in 6 of 38 incisions repaired with polyglactin 910, and 3 sites developed scar hypertrophy. Conversely, 3 of 38 incisions closed with polydioxanone revealed scar spread (p < 0.25), and 3 were hypertrophic (p < 0.35). Sixty-one sites healed with undiscernible scars. This study does not disclose any statistically significant difference in the quality of the scars when polyglactin 910 is used compared with polydioxanone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823020     DOI: 10.1097/00006534-199610000-00010

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Tissue reaction and surface morphology of absorbable sutures after in vivo exposure.

Authors:  Miguel G S Andrade; Ruben Weissman; Sílvia R A Reis
Journal:  J Mater Sci Mater Med       Date:  2006-10       Impact factor: 3.896

2.  Comparison of Two Tube-Modification Techniques in Baerveldt Glaucoma Implantation in Refractory Glaucoma.

Authors:  Purit Petpiroon; Thanyathorn Vijittrakarnrung; Wasu Supakontanasan; Apichat Tantraworasin; Yanin Suwan
Journal:  Clin Ophthalmol       Date:  2020-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.